Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Outcomes of Lung Transplantation From Hepatitis C Viremic Donors
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Outcomes of Lung Transplantation From Hepatitis C Viremic Donors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
1-year Mortality
12%
Acute Rejection
12%
Adult Patients
12%
Chronic Infection
12%
Direct-acting Antiviral Therapy
12%
Distance Traveled
12%
Donor Lung
12%
Early Complications
12%
Early Survival
12%
FiO2
12%
Hepatitis C
100%
Hepatitis C Virus
100%
Incomplete Data
12%
Loss-to-follow-up
12%
Lung
62%
Lung Allocation Score
12%
Lung Transplantation
100%
Mortality Rate
12%
Multiorgan Transplantation
12%
Nationwide Data
12%
Nucleic Acid Testing
75%
PaO2
12%
Propensity Matching
12%
Reintubation
12%
Seroconversion
12%
Short-term Outcomes
12%
United Network for Organ Sharing
12%
Viremia
12%
Viremic Donor
100%
Virus nucleic Acid
25%
Virus Status
12%
Medicine and Dentistry
Antiviral Therapy
12%
Chronic Graft Rejection
12%
Hepatitis C
100%
Hepatitis C Virus
100%
Infection
12%
Lung
87%
Lung Transplantation
100%
Mortality Rate
12%
Nucleic Acid
75%
Seroconversion
12%
Transplantation
12%
Viremia
12%